Stay updated with breaking news from Daron Evans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
13.02.2024 - Phase 3 clinical study of RZ358 underway in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Benefit shown in individual patient cases with RZ358 for tumor-associated hyperinsulinism (taHI) under Expanded Access ...
REDWOOD CITY, Calif., Jan. 24, 2024 -- Rezolute, Inc. , a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare...
Operator: Good day, and welcome to the Envelope Enterprise Holdings Second Half and Fiscal Year 2022 Earnings Conference Call. Please note, this event is being recorded.